Blood protein may reveal clues about ankylosing spondylitis
NCT ID NCT07117344
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at a protein called progranulin in the blood of people with ankylosing spondylitis (a type of arthritis that affects the spine) and compares it to healthy volunteers. Researchers want to see if progranulin levels are linked to disease activity and whether they change with TNF-α inhibitor treatment. The goal is to find a new biomarker that could help monitor the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS (AS) / RADIOGRAPHIC AXIAL SPA (R-AXSPA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kırşehir Ahi Evran University
Kırşehir, 40100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.